The spin-out tag makes university start-ups look weak and vulnerable, says Philip Sharpe from QinetiQ, one of Europe’s largest technology commercialisation companies.
Alexander von Gabain and his team laid the foundations of an enterprise that would rise to the top of the continent’s biotechnology pile – and rewrite the region’s rules for biotechnology start-ups.
Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.
Most of the Cohesion Policy budget of €347 million is being invested in projects that support the Lisbon strategy, according to the latest analysis of the programme.
Research Commissioner Janez Potocnik called for Europe to adopt a global culture of entrepreneurship in the face of the challenge from China and India.
The European Parliament has given the thumbs up to the first ever Europe-wide public–private research partnerships, approving programmes in miniaturisation, embedded computers, medicines and aviation.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.